Modus Therapeutics Holding AB

Research Modus Therapeutics Holding AB (MODTX) on Bullrun: market cap SEK 56.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMODTX
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 56.80M
• Financial periodQ4 2025
• Net income-SEK 5.32M
• Free cash flow-SEK 5.00M

Valuation Snapshot

latest market cap is SEK 56.80M.

About Modus Therapeutics Holding AB

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

Frequently asked questions

What is Modus Therapeutics Holding AB's market cap?

Modus Therapeutics Holding AB's market capitalization is SEK 56.80M.

What does Modus Therapeutics Holding AB do?

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden.